SK Biopharm, Q1 Operating Profit Turns Positive at 75.9 Billion KRW... Sales Reach 140 Billion KRW

[Asia Economy Reporter Gong Byung-sun] SK Biopharm announced on the 12th that it recorded an operating profit of 75.9 billion KRW in the first quarter of this year, turning to a profit.

Sales reached 140 billion KRW, an increase of 3464.06% compared to the same period last year. Net profit for the period was 128.9 billion KRW, also turning to a profit.